Research studies involving people are called clinical trials. The are 2 main types of clinical trial.
Interventional trials aim to find out more about a particular treatment. People taking part are put into treatment groups and the research team compare the results between groups.
Observational studies aim to find out what happens to people in different situations. The research team observe the people taking part without changing what treatments people have. HUNTER is an observational trial therefore participating will not change the standard of care.
You can find out more about different types of clinical trails here.
To participate in HUNTER you must be under the care of a clinician at one of the participating sites. Your clinical team will be able to advise if you fit the inclusion criteria.
Samples will either be used in experiments straight away, or they may be stored to use in experiments in the future. This is all carried out according to protocols approved by the Research Ethics Committee.
You can read more about the ongoing research here
The HUNTER cinical trial will close in 2023. It can take several years to analyse all the data.......
The results may be presented at scientific meetings and published in scientific journals. Your name or any other details that may identify you will not be used in any publications. If you wish to receive copies of any published results, please contact us.
The study involves you giving consent for some extra blood (about two ‐ three tablespoons) to be taken at the same time as routine blood samples. These may be taken during outpatient clinic visits as well as before and after investigations or treatments on the liver, surgical or oncology wards. You could also be asked for extra samples (at the same time as routine samples) at your follow up appointments.
In addition we may collect left over tissue from your liver after a liver biopsy or a liver operation. (This would not involve any extra procedure on you). After the study is finished we’d like to keep your samples for use in future studies. We will record information about you such as your name, age, gender, your liver function and stage of disease, any procedures you undergo, details of the treatment you receive, as well as how you respond to the treatment.
The study is being organised by Newcastle University, funded through a partnership between Cancer Research UK, Fondazione AIRC and Fundación Científica de la Asociacion Española Contra el Cáncer, and sponsored by the Newcastle upon Tyne Hospitals NHS Foundation Trust.